pÓs asco gu 2018 testicular câncer · 2- general session: manejo de massas residuais pós...

47

Upload: dangminh

Post on 27-Jul-2018

212 views

Category:

Documents


0 download

TRANSCRIPT

[email protected]

PÓS ASCO GU 2018

Testicular Câncer

ANA PAULA GARCIA CARDOSO

MD, HOSPITAL ISRAELITA ALBERT EINSTEIN

PÓS ASCO GU 2018Testicular Cancer

ANA PAULA GARCIA CARDOSOMD, HOSPITAL ISRAELITA ALBERT EINSTEIN

1- Keynote Letter: Manejo de Câncer de Testículo estadio II (A) com marcador tumoral negativo

2- General Session: Manejo de massas residuais pós quimioterapia Abstract 546- Serum miRNA to predict post-chemotherapy viable disease in testicular non-

seminomatous germ cell tumor patients.

3- Rapid-Fire Abstract Session: Abstract 550- Sentinel node biopsy in clinical stage I testicular cancer; Abstract 549- Long-term sexual functioning in germ-cell tumor survivors; Abstract 551- Impact of medicaid expansion on diagnosis and management of patients with

testicular cancer

4- Poster: Abstract 548- Collateral damage: Molecular aging and p16INK4a senescence protein in testicular

cancer survivors treated with chemotherapy. Abstract 564- Effect of number of computed tomography (CT) scans during follow-up (FUP) of

patients with clinical stage I (CSI) seminoma: A trial-level meta-analysis. Abstract 556 -Diagnostic radiation and testicular germ cell tumor risk.

[email protected]

Serum miRNA to predict <br />post-chemotherapy viable disease in testicular nonseminomatous <br />germ cell tumor patients

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Background

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

The problem...

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

miRNAs in Testicular Cancer

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Hypothesis

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Patients and Methods

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Patients and Methods

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Conclusions/Take-Home Points

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Limitations

Presented By Ricardo Leao at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Sentinel Node Biopsy in <br />Clinical Stage I Testicular Cancer

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Slide 2

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Sentinel Lymph Node Biopsy

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Slide 4

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Lymphoscintigraphy & SPECT/CT

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Slide 7

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Slide 9

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Follow-up results

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Slide 11

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Take-home messages

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Adjusted treatment?

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

However…

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

SENATOR Study

Presented By Joost Blok at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Long-term sexual functioning in germ-cell tumor survivors

Presented By Michal Chovanec at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Background

Presented By Michal Chovanec at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Study design and participants

Presented By Michal Chovanec at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Education, job, marital status and fatherhood

Presented By Michal Chovanec at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Michal Chovanec at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Michal Chovanec at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Michal Chovanec at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Results

Presented By Michal Chovanec at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Sexual impairment and levels of testosterone

Presented By Michal Chovanec at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Limitations

Presented By Michal Chovanec at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Conclusions

Presented By Michal Chovanec at 2018 Genitourinary Cancers Symposium: Translating Evidence to Multidisciplinary Care

[email protected]

Estudos geradores de hipóteses, nenhum ”practice changing”:

1- Manejo de massas residuais pós quimioterapia Abstract 546- Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ

cell tumor patients.

2- Biópsia de LN sentinela como ferramenta de seleção de pacientes ECI q vão receber tratamento adjuvante ou definir melhor o seguimento desses pacientes, inclusive sobre a frequência de exames de imagem que vão realizar

Abstract 550- Sentinel node biopsy in clinical stage I testicular cancer;

3- Toxicidade a longo prazo – importância da disfunção sexual na qualidade de vida de pacientes sobreviventes ao pacientes sobreviventes ao tratamento de câncer de testículo

Abstract 549- Long-term sexual functioning in germ-cell tumor survivors;

PÓS ASCO GU 2018Testicular C^ncer

ANA PAULA GARCIA CARDOSOHOSPITAL ISRAELITA ALBERT EINSTEIN

CONCLUSÃO

[email protected]

OBRIGADA!